DescriptionPrototype for a Universal Flu Vaccine (48706389381).png
A Colorized structure of a prototype for a universal flu vaccine, known as H1ssF_3928, which is being evaluated as part of a Phase 1 clinical trial at the NIH Clinical Center in Bethesda, MD. The vaccine nanoparticle, designed by Jeffrey Boyington (VRC), is a hybrid of a protein scaffold (blue) and eight influenza hemagglutinin proteins arrayed on the surface (yellow). The hemagglutinin protein was specifically engineered to display antibody binding sites common to all human influenza subtypes. The 3D structure of the particle was determined by cryo-electron microscopy by John Gallagher and Audray Harris (Laboratory of Infectious Diseases). Credit: NIAID
to share – to copy, distribute and transmit the work
to remix – to adapt the work
Under the following conditions:
attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
https://creativecommons.org/licenses/by/2.0CC BY 2.0 Creative Commons Attribution 2.0 truetrue